Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 76

Whole-genome sequencing detects coding, noncoding, copy-number, and structural DNA variants. Learn how WGS works, what results mean, its blind spots, and reanalysis.

Whole-Genome Sequencing (WGS) Method: DNA Variants, Structural Changes, and Results

Understand the achondroplasia FGFR3 genetic test, including common p.Gly380Arg variants, result meanings, inheritance risks, testing methods, and follow-up.

Achondroplasia Genetic Test: FGFR3 Gene Mutation and Results

Learn how SERPINA1 genetic testing confirms alpha-1 antitrypsin deficiency, explains MM, MZ, SZ, and ZZ results, and guides lung, liver, and family follow-up.

Alpha-1 Antitrypsin Deficiency Genetic Test: SERPINA1 Gene, Liver, Lung, and Results

Understand alpha-thalassemia HBA1 and HBA2 testing, including deletions, cis and trans carrier results, hemoglobin H disease, partner risk, and pregnancy follow-up.

Alpha-Thalassemia Genetic Test: HBA1, HBA2 Deletions, Carrier Risk, and Results

Learn how COL4A3, COL4A4, and COL4A5 testing diagnoses Alport syndrome, distinguishes inheritance patterns, explains VUS and negative results, and guides kidney and family care.

Alport Syndrome Genetic Test: COL4A3, COL4A4, COL4A5, and Results

Understand Ashkenazi Jewish carrier screening panels, common conditions, founder versus expanded testing, carrier results, residual risk, partner testing, and reproductive options.

Ashkenazi Jewish Genetic Carrier Screening Panel: Common Conditions and Results

Learn how autosomal recessive carrier screening results combine with partner testing to define couple risk, residual risk, and reproductive options.

Autosomal Recessive Carrier Screening Test: Partner Risk and Results

Understand how DMD gene testing confirms Becker muscular dystrophy, detects deletions and sequence variants, predicts phenotype, and guides family care.

Becker Muscular Dystrophy Genetic Test: DMD Gene Mutations and Results

Learn how HBB genetic testing diagnoses beta-thalassemia, identifies carriers, clarifies partner risk, and explains positive, negative, and uncertain results.

Beta-Thalassemia Genetic Test: HBB Gene Mutations, Carrier Risk, and Results

Learn how BTD genetic testing and enzyme activity confirm profound or partial biotinidase deficiency, explain variants, and guide treatment and family risk.

Biotinidase Deficiency Genetic Test: BTD Gene Mutations and Results

Learn how ASPA carrier testing identifies Canavan disease risk, compares founder panels with full-gene testing, and guides partner and pregnancy decisions.

Canavan Disease Carrier Test: ASPA Gene, Carrier Risk, and Results

Understand how CYP21A2 testing confirms 21-hydroxylase-deficient CAH, resolves pseudogene and deletion complexity, and explains disease and carrier results.

Congenital Adrenal Hyperplasia Genetic Test: CYP21A2 Gene and Results

Learn how CFTR carrier testing identifies cystic fibrosis risk, compares panels with sequencing, explains complex variants, and guides partner testing.

Cystic Fibrosis Carrier Test: CFTR Gene Mutations, Risk, and Results

Learn how DMD gene testing diagnoses Duchenne muscular dystrophy, detects deletions and sequence variants, explains results, and guides family care.

Duchenne Muscular Dystrophy Genetic Test: DMD Gene Mutations and Results

Understand Ehlers-Danlos genetic testing for COL5A1, COL5A2, and COL3A1, including classic and vascular EDS results, negative panels, VUS findings, family risk, and next steps.

Ehlers-Danlos Syndrome Genetic Test: COL5A1, COL5A2, COL3A1, and Results

Learn how expanded carrier screening evaluates genetic disease risk, how panel genes and methods differ, what positive and negative results mean, and how partner findings guide pregnancy options.

Expanded Carrier Screening Test: Genetic Disease Risk, Genes, and Results

1...757677...137 Page 76 of 137